Correlation Between Pasithea Therapeutics and Palisade Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Palisade Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Palisade Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Palisade Bio, you can compare the effects of market volatilities on Pasithea Therapeutics and Palisade Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Palisade Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Palisade Bio.

Diversification Opportunities for Pasithea Therapeutics and Palisade Bio

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pasithea and Palisade is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Palisade Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Palisade Bio and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Palisade Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Palisade Bio has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Palisade Bio go up and down completely randomly.

Pair Corralation between Pasithea Therapeutics and Palisade Bio

Given the investment horizon of 90 days Pasithea Therapeutics Corp is expected to generate 0.57 times more return on investment than Palisade Bio. However, Pasithea Therapeutics Corp is 1.76 times less risky than Palisade Bio. It trades about -0.24 of its potential returns per unit of risk. Palisade Bio is currently generating about -0.25 per unit of risk. If you would invest  369.00  in Pasithea Therapeutics Corp on August 28, 2024 and sell it today you would lose (64.00) from holding Pasithea Therapeutics Corp or give up 17.34% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pasithea Therapeutics Corp  vs.  Palisade Bio

 Performance 
       Timeline  
Pasithea Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pasithea Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Palisade Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Palisade Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pasithea Therapeutics and Palisade Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pasithea Therapeutics and Palisade Bio

The main advantage of trading using opposite Pasithea Therapeutics and Palisade Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Palisade Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Palisade Bio will offset losses from the drop in Palisade Bio's long position.
The idea behind Pasithea Therapeutics Corp and Palisade Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk